LGD-4033 and Liothyronine (T3) Interaction

Monitor
Mechanism-based 51% confidence

LGD-4033 and Liothyronine (T3) have an interaction requiring monitoring for interaction with 51% confidence. Both LGD-4033 and Liothyronine (T3) can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). These compounds primarily affect different organ systems.

Compound Profiles

LGD-4033

Selective Androgen Receptor Modulator | Lean Mass

LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.

Half-life: ~24-36 hours Typical dose: 5-10 mg/day sarm, anabolic
androgen receptorepo receptor androgenicblood pressure raisingcarcinogenic riskestrogenic
View full profile

Liothyronine (T3)

Thyroid Hormone | Metabolic Optimization

Liothyronine enters target cells via monocarboxylate transporter 8 (MCT8) and other thyroid hormone transporters, then binds to nuclear thyroid hormone receptors (primarily TR-beta in metabolic tissues and TR-alpha in cardiac tissue). The T3-receptor complex forms heterodimers with retinoid X receptors (RXR) and binds to thyroid hormone response elements (TREs) on DNA, directly modulating gene transcription.

Half-life: ~1 day Typical dose: 25-75 mcg/day (replacement) metabolic, weight loss
thyroid receptor blood pressure raisingcardiotoxic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds raise blood pressure (LGD-4033, Liothyronine (T3)). Monitor BP daily and consider cardiovascular support.

Frequently Asked Questions

Can I take LGD-4033 with Liothyronine (T3)?

Yes, but with caution. Both LGD-4033 and Liothyronine (T3) can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). Regular monitoring is advised.

Is LGD-4033 and Liothyronine (T3) safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: blood pressure raising. Monitor accordingly.

What are the interactions between LGD-4033 and Liothyronine (T3)?

Both LGD-4033 and Liothyronine (T3) can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time LGD-4033 and Liothyronine (T3)?

LGD-4033 has a half-life of ~24-36 hours and Liothyronine (T3) has a half-life of ~1 day. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: LGD-4033 vs Liothyronine (T3)

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.